Series A startups in Boston, Massachusetts
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| Mindgard | Boston | Series A | $30.0M | 2026-08-12 |
| Dash Bio | Boston | Series A | $30.0M | 2026-08-03 |
| InStockRx | Boston | Series A | $5.0M | 2026-07-01 |
| Catena | Boston | Series A | $30.0M | 2026-05-20 |
| Vector | Boston | Series A | $10.0M | 2026-05-13 |
| Blitzy | Boston | Series A | $200.0M | 2026-05-05 |
| Lambent | Boston | Series A | $11.5M | 2026-03-24 |
| Coral Care | Boston | Series A | $13.0M | 2026-02-23 |
8 rows of the CSV in 5 of its 18 columns.
- The 279 series a startups in Boston, Massachusetts have raised $8.5B in total.
- 32 of them closed their most recent round in the last 12 months, $1.3B combined.
- The largest of those rounds is Solstice Oncology's $225.0M Series A, dated September 2026.
- The most recent is Signet Therapeutics' $11.5M Series A on 4 November 2026.
- MassChallenge is an investor in 11 of them, more than any other fund.
- Software is the most common sector, with 146 companies (52%).
- 28% were founded in 2020 or later; the median founding year is 2017.
- The most common team size is 11 to 50 employees (63% of companies with a recorded size).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
30 of 279| Company | What they do | Sector | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|
| Mindgard | Mindgard provides AI Red Teaming solutions to identify and mitigate vulnerabilities in artificial intelligence systems. | Artificial intelligence | Series A | $30.0M | 2026-08-12 | $41.9M | Lakestar, IQ Capital, Osney Capital | 11 to 50 | 2022 |
| Dash Bio | Dash Bio develops automated laboratory workflows and software to support drug development through bioanalysis services. | Artificial intelligence | Series A | $30.0M | 2026-08-03 | $47.5M | Freestyle Capital, Swift Ventures, LifeX Ventures +1 | 11 to 50 | 2024 |
| InStockRx | InStockRx connects licensed pharmacies to buy and sell inventory with each other. | Commerce | Series A | $5.0M | 2026-07-01 | $5.1M | Techstars | 1 to 10 | 2020 |
| Catena | Catena incubates independent products in identity, communications, AI, and commerce. | Artificial intelligence | Series A | $30.0M | 2026-05-20 | $48.0M | Circle Ventures, Breyer Labs | 1 to 10 | 2022 |
| Vector | Vector helps B2B sales reps and SDRs generate pipeline by activating their company's network instead of cold prospecting. | Software | Series A | $10.0M | 2026-05-13 | $10.0M | Y Combinator, NC Tweener Fund, Eight Capital | 1 to 10 | 2022 |
| Blitzy | Blitzy automates custom software development using generative AI technology. | Artificial intelligence | Series A | $200.0M | 2026-05-05 | $210.4M | Bessemer Venture Partners, NFX, Picus Capital +2 | 101 to 250 | 2023 |
| Lambent | Lambent provides a Boston-based SaaS analytics platform for data-driven real estate decisions on campuses. | Hardware | Series A | $11.5M | 2026-03-24 | $38.6M | Inovia Capital, MassVentures, Glasswing Ventures +2 | 11 to 50 | 2017 |
| Coral Care | Coral Care connects families with licensed speech, occupational, and physical therapists through a pediatric therapy platform. | Health care | Series A | $13.0M | 2026-02-23 | $19.5M | Hustle Fund, Reach Capital, AlleyCorp +2 | 11 to 50 | 2023 |
| Third Arc Bio | Third Arc Bio develops multifunctional antibodies for inflammatory and immunology diseases. | Biotech | Series A | $52.0M | 2026-02-04 | $217.0M | T. Rowe Price, Cormorant Asset Management, Foresite Capital +1 | 11 to 50 | 2022 |
| EnFi | EnFi provides services that speed up complex credit analysis and risk monitoring. | Artificial intelligence | Series A | $15.0M | 2026-02-04 | $22.5M | Unusual Ventures, Boston Seed Capital, Argon Ventures +1 | 11 to 50 | 2023 |
| Neurable | Neurable develops AI tools for translating brain signals and brain-computer interface technology. | Artificial intelligence | Series A | $35.0M | 2025-12-19 | $57.3M | National Science Foundation, Global Brain Corporation, Metaplanet +1 | 11 to 50 | 2015 |
| AI Proteins | AI Proteins designs and engineers miniprotein therapeutics using artificial intelligence. | Artificial intelligence | Series A | $42.5M | 2025-11-19 | $80.4M | Intel Ignite, Lightchain Capital, Cobro Ventures | 11 to 50 | 2021 |
| FamilyWell Health | FamilyWell Health provides integrated mental health services for pregnant and postpartum patients. | Health care | Series A | $8.0M | 2025-11-18 | $13.3M | .406 Ventures, GreyMatter, Springboard Enterprises +1 | 11 to 50 | 2022 |
| Agency AI | Agency AI manages workflows for B2B customer success teams. | Artificial intelligence | Series A | $20.0M | 2025-11-12 | $32.0M | Sequoia Capital, HubSpot Ventures | 1 to 10 | 2023 |
| OnRamp | OnRamp provides customer onboarding software with guided workflows and automation for businesses. | Software | Series A | $15.0M | 2025-11-12 | $31.2M | Quiet Capital, Pear VC, Correlation Ventures +2 | 11 to 50 | 2019 |
| Folia Health | Folia Health is a platform that securely captures and shares users' health and symptom data. | Biotech | Series A | $10.5M | 2025-10-01 | $17.4M | MassChallenge, Social Starts, Bantam Group +2 | 11 to 50 | 2016 |
| Kodex | Kodex provides a web platform for managing relationships, workflows, and secure file transfer with government agencies. | Software | Series A | $21.2M | 2025-09-17 | $41.2M | Y Combinator, Tusk Venture Partners | 11 to 50 | 2021 |
| Eyebot | Eyebot develops eye examination technology to expand access to quality vision care. | Artificial intelligence | Series A | $20.0M | 2025-08-26 | $29.9M | National Science Foundation, Village Global, MassVentures +2 | 11 to 50 | 2021 |
| AllSpice.io | AllSpice.io provides a platform that helps hardware teams manage, review, and collaborate on designs. | Software | Series A | $15.0M | 2025-06-23 | $25.3M | Flybridge, Bowery Capital, Root Ventures +2 | 11 to 50 | 2020 |
| PhaseV | PhaseV provides AI-driven solutions for clinical development and operations. | Artificial intelligence | Series A | $50.0M | 2025-05-13 | $65.0M | Viola Ventures, LionBird, GETTY +1 | 11 to 50 | 2023 |
| Lynx | Lynx provides an API-driven platform that lets businesses integrate healthcare financial services, payments, banking, and investments. | Fintech | Series A | $27.0M | 2025-02-06 | $44.5M | .406 Ventures, Obvious Ventures, Frist Cressey Ventures +2 | 11 to 50 | 2021 |
| ZETA SURGICAL | ZETA SURGICAL provides real-time frameless navigation for brain surgery, deployable beyond the operating room. | Artificial intelligence | Series A | $5.0M | 2025-01-21 | $13.9M | Y Combinator, Artesian VC, Brinc +2 | 11 to 50 | 2018 |
| Claim | Claim is a social app that lets users earn and trade rewards with friends. | Software | Series A | $12.0M | 2024-10-08 | $18.0M | Sequoia Capital, BoxGroup, 6th Man Ventures +2 | 11 to 50 | 2021 |
| Opmed.ai | Opmed.ai provides technologies and services for hospitals and healthcare providers. | Health care | Series A | $15.0M | 2024-05-06 | $15.0M | NFX, Grove Ventures, Secret Chord Ventures +1 | 11 to 50 | 2020 |
| Adaptilens | Adaptilens develops an accommodating intraocular lens for cataract patients. | Biotech | Series A | $17.5M | 2024-04-29 | $19.1M | MassChallenge, Pillar VC, Perceptive Advisors +2 | 1 to 10 | 2019 |
| Ascidian Therapeutics | Ascidian Therapeutics is a biotechnology company focused on medical and clinical gene therapy. | Biotech | Series A | $40.0M | 2023-11-08 | $90.0M | Apple Tree Partners | 11 to 50 | 2020 |
| Slang | Slang offers online specialized English courses for career development using a proprietary machine learning engine. | Artificial intelligence | Series A | $4.0M | 2023-08-23 | $25.0M | Bossa Invest, Salesforce Ventures, DGF +1 | 11 to 50 | 2013 |
| P0x Labs | P0x Labs is the team behind Manta Network, a privacy-preserving technology on the Polkadot blockchain. | Fintech | Series A | $25.0M | 2023-07-19 | $31.6M | Qiming Venture Partners, Polychain, LongHash Ventures +1 | 11 to 50 | 2020 |
| BlockJoy | BlockJoy provides Web3 infrastructure that lets users run their own blockchain nodes on any infrastructure. | Software | Series A | $12.0M | 2023-02-02 | $14.1M | Bessemer Venture Partners, Gradient, Borderless Capital +2 | 1 to 10 | 2021 |
| Schola | Schola is a platform that helps families find and enroll in suitable PreK-12 schools. | Education | Series A | $10.0M | 2022-12-28 | $14.4M | Kickstart, Revolution’s Rise of the Rest Seed Fund, Stout Street Capital +2 | 51 to 100 | 2016 |
Table 1. Series A startups in Boston, Massachusetts: the 30 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 279.
Largest rounds
Last 12 months| # | Company | What they do | Sector | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Blitzy | Blitzy automates custom software development using generative AI technology. | Artificial intelligence | Series A | $200.0M | 2026-05-05 | $210.4M | Bessemer Venture Partners, NFX, Picus Capital +2 | 101 to 250 | 2023 |
| 2 | Third Arc Bio | Third Arc Bio develops multifunctional antibodies for inflammatory and immunology diseases. | Biotech | Series A | $52.0M | 2026-02-04 | $217.0M | T. Rowe Price, Cormorant Asset Management, Foresite Capital +1 | 11 to 50 | 2022 |
| 3 | AI Proteins | AI Proteins designs and engineers miniprotein therapeutics using artificial intelligence. | Artificial intelligence | Series A | $42.5M | 2025-11-19 | $80.4M | Intel Ignite, Lightchain Capital, Cobro Ventures | 11 to 50 | 2021 |
| 4 | Neurable | Neurable develops AI tools for translating brain signals and brain-computer interface technology. | Artificial intelligence | Series A | $35.0M | 2025-12-19 | $57.3M | National Science Foundation, Global Brain Corporation, Metaplanet +1 | 11 to 50 | 2015 |
| 5 | Mindgard | Mindgard provides AI Red Teaming solutions to identify and mitigate vulnerabilities in artificial intelligence systems. | Artificial intelligence | Series A | $30.0M | 2026-08-12 | $41.9M | Lakestar, IQ Capital, Osney Capital | 11 to 50 | 2022 |
| 6 | Dash Bio | Dash Bio develops automated laboratory workflows and software to support drug development through bioanalysis services. | Artificial intelligence | Series A | $30.0M | 2026-08-03 | $47.5M | Freestyle Capital, Swift Ventures, LifeX Ventures +1 | 11 to 50 | 2024 |
| 7 | Catena | Catena incubates independent products in identity, communications, AI, and commerce. | Artificial intelligence | Series A | $30.0M | 2026-05-20 | $48.0M | Circle Ventures, Breyer Labs | 1 to 10 | 2022 |
| 8 | EnFi | EnFi provides services that speed up complex credit analysis and risk monitoring. | Artificial intelligence | Series A | $15.0M | 2026-02-04 | $22.5M | Unusual Ventures, Boston Seed Capital, Argon Ventures +1 | 11 to 50 | 2023 |
| 9 | Coral Care | Coral Care connects families with licensed speech, occupational, and physical therapists through a pediatric therapy platform. | Health care | Series A | $13.0M | 2026-02-23 | $19.5M | Hustle Fund, Reach Capital, AlleyCorp +2 | 11 to 50 | 2023 |
| 10 | Lambent | Lambent provides a Boston-based SaaS analytics platform for data-driven real estate decisions on campuses. | Hardware | Series A | $11.5M | 2026-03-24 | $38.6M | Inovia Capital, MassVentures, Glasswing Ventures +2 | 11 to 50 | 2017 |
Table 2. Series A startups in Boston, Massachusetts: the 10 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | MassChallenge | Startup accelerator | Boston, United States | 11 | 4% | ||
| 2 | Alumni Ventures | Angel group | Manchester, United States | 10 | 4% | ||
| 3 | Techstars | Startup accelerator | New York, United States | 9 | 3% | 1 | InStockRx |
| 4 | .406 Ventures | Venture capital firm | Boston, United States | 7 | 3% | 1 | FamilyWell Health |
| 5 | Bantam Group | Angel group | Westwood, United States | 5 | 2% | ||
| 6 | Underscore VC | Venture capital firm | Boston, United States | 5 | 2% | ||
| 7 | Y Combinator | Startup accelerator | Mountain View, United States | 4 | 1% | 1 | Vector |
| 8 | MassVentures | Venture capital firm | Boston, United States | 4 | 1% | 1 | Lambent |
| 9 | Pillar VC | Venture capital firm | Boston, United States | 4 | 1% | ||
| 10 | Accomplice | Family office | Cambridge, United States | 4 | 1% | ||
| 11 | Bain Capital Ventures | Venture capital firm | San Francisco, United States | 4 | 1% | ||
| 12 | NFX | Startup accelerator | San Francisco, United States | 3 | 1% | 1 | Blitzy |
| 13 | Bessemer Venture Partners | Venture capital firm | San Francisco, United States | 3 | 1% | 1 | Blitzy |
| 14 | Inovia Capital | Venture capital firm | Montréal, Canada | 3 | 1% | 1 | Lambent |
| 15 | Boston Seed Capital | Venture capital firm | Boston, United States | 3 | 1% | 1 | EnFi |
Table 3. Series A startups in Boston, Massachusetts: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Software | 146 | 52% | $3.2B |
| Health care | 97 | 35% | $3.5B |
| Biotech | 57 | 20% | $2.8B |
| Artificial intelligence | 51 | 18% | $1.7B |
| Hardware | 40 | 14% | $780.9M |
| Commerce | 31 | 11% | $1.3B |
| Fintech | 29 | 10% | $1.2B |
| Cybersecurity | 21 | 8% | $1.2B |
| Education | 19 | 7% | $194.4M |
| Energy | 9 | 3% | $50.0M |
Table 4. Series A startups in Boston, Massachusetts by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
| Funding stage | Companies | Share | Median last round |
|---|---|---|---|
| Series A | 279 | 100% | $11.0M |
Table 5. Series A startups in Boston, Massachusetts by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| November 2026 | 1 | 3% | $11.5M |
| October 2026 | 1 | 3% | $30.0M |
| September 2026 | 3 | 9% | $251.0M |
| August 2026 | 3 | 9% | $61.5M |
| July 2026 | 2 | 6% | $80.0M |
| June 2026 | 3 | 9% | $71.6M |
| May 2026 | 5 | 16% | $245.0M |
| March 2026 | 2 | 6% | $30.5M |
| February 2026 | 3 | 9% | $80.0M |
| January 2026 | 2 | 6% | $130.0M |
| December 2025 | 4 | 12% | $185.0M |
| November 2025 | 3 | 9% | $140.5M |
Table 6. Series A startups in Boston, Massachusetts: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 25 | 9% | $991.0M |
| 2025 | 39 | 14% | $1.3B |
| 2024 | 16 | 6% | $485.4M |
| 2023 | 23 | 8% | $369.7M |
| 2022 | 33 | 12% | $393.6M |
| 2021 | 24 | 9% | $1.8B |
Table 7. Series A startups in Boston, Massachusetts by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2023 or later | 26 | 9% |
| 2020 to 2022 | 51 | 18% |
| 2015 to 2019 | 101 | 37% |
| 2010 to 2014 | 61 | 22% |
| Before 2010 | 37 | 13% |
Table 8. Series A startups in Boston, Massachusetts by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 46 | 17% |
| 11 to 50 | 176 | 63% |
| 51 to 100 | 37 | 13% |
| 101 to 250 | 13 | 5% |
| 251 to 500 | 3 | 1% |
| 501 to 1,000 | 2 | 1% |
| 10,001 or more | 1 | 0% |
Table 9. Series A startups in Boston, Massachusetts by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when its most recent funding round is Series A and its headquarters is in Boston, Massachusetts. On 16 November 2026 that is 279 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 30 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 279 rows: 37 have no round amount, 0 no city and 25 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many series a startups in Boston, Massachusetts are on the list?
- 279, in the file dated 16 November 2026. 32 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 279 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.